StonvexLoading…
StonvexStonvexStonvexCore line items from PRVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.12B | $1.74B | $1.66B | $1.36B |
Operating Income | $34.23M | $16.98M | $20.65M | $-19.12M |
Net Income | $22.92M | $14.38M | $23.08M | $-8.59M |
EPS (Diluted) | $0.18 | $0.11 | $0.19 | $-0.08 |
Total Assets | $1.37B | $1.14B | $999.90M | $792.81M |
Total Liabilities | $578.43M | $452.34M | $392.51M | $273.76M |
Cash & Equivalents | $479.69M | $491.15M | $389.51M | $347.99M |
Free Cash Flow OCF − CapEx | Not available | Not available | $80.67M | $47.09M |
Shares Outstanding | 123.60M | 120.31M | 118.22M | 114.69M |